These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15031787)

  • 41. Reconstitution of NK cell activity in HIV-1 infected individuals receiving antiretroviral therapy.
    Weber K; Meyer D; Grosse V; Stoll M; Schmidt RE; Heiken H
    Immunobiology; 2000 Aug; 202(2):172-8. PubMed ID: 10993291
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immune activation in chronic HIV infection.
    Ostrowski SR
    Dan Med Bull; 2010 Mar; 57(3):B4122. PubMed ID: 20298670
    [No Abstract]   [Full Text] [Related]  

  • 43. The effects of hepatitis C virus core protein on functional responses in the NK cell line YTS.
    Dominguez-Villar M; Garcia-Cozar FJ; Chambers BJ
    Scand J Immunol; 2012 Jan; 75(1):54-60. PubMed ID: 21916918
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pathologic natural killer cell subset redistribution in HIV-1 infection: new insights in pathophysiology and clinical outcomes.
    Brunetta E; Hudspeth KL; Mavilio D
    J Leukoc Biol; 2010 Dec; 88(6):1119-30. PubMed ID: 20651298
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CD56 negative NK cells: origin, function, and role in chronic viral disease.
    Björkström NK; Ljunggren HG; Sandberg JK
    Trends Immunol; 2010 Nov; 31(11):401-6. PubMed ID: 20829113
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates.
    Mavilio D; Benjamin J; Daucher M; Lombardo G; Kottilil S; Planta MA; Marcenaro E; Bottino C; Moretta L; Moretta A; Fauci AS
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15011-6. PubMed ID: 14645713
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Persistent Replication of HIV, Hepatitis C Virus (HCV), and HBV Results in Distinct Gene Expression Profiles by Human NK Cells.
    Boeijen LL; Hou J; de Groen RA; Verbon A; Boonstra A
    J Virol; 2019 May; 93(9):. PubMed ID: 30185599
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Escape of monocyte-derived dendritic cells of HIV-1 infected individuals from natural killer cell-mediated lysis.
    Tasca S; Tambussi G; Nozza S; Capiluppi B; Zocchi MR; Soldini L; Veglia F; Poli G; Lazzarin A; Fortis C
    AIDS; 2003 Nov; 17(16):2291-8. PubMed ID: 14571180
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of NK Cell Subpopulations That Differentiate HIV-Infected Subject Cohorts with Diverse Levels of Virus Control.
    Pohlmeyer CW; Gonzalez VD; Irrinki A; Ramirez RN; Li L; Mulato A; Murry JP; Arvey A; Hoh R; Deeks SG; Kukolj G; Cihlar T; Pflanz S; Nolan GP; Min-Oo G
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30700608
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of the Inhibitory Receptor TIGIT Is Up-Regulated Specifically on NK Cells With CD226 Activating Receptor From HIV-Infected Individuals.
    Yin X; Liu T; Wang Z; Ma M; Lei J; Zhang Z; Fu S; Fu Y; Hu Q; Ding H; Han X; Xu J; Shang H; Jiang Y
    Front Immunol; 2018; 9():2341. PubMed ID: 30364127
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [NK cells, chemokines and chemokine receptors].
    Kopecký J; Kopecký O
    Klin Onkol; 2010; 23(1):5-9. PubMed ID: 20192067
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Switch from inhibitory to activating NKG2 receptor expression in HIV-1 infection: lack of reversion with highly active antiretroviral therapy.
    Mela CM; Burton CT; Imami N; Nelson M; Steel A; Gazzard BG; Gotch FM; Goodier MR
    AIDS; 2005 Nov; 19(16):1761-9. PubMed ID: 16227783
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 in the presence of natural-killer effector cells.
    Forthal DN; Landucci G; Daar ES
    J Virol; 2001 Aug; 75(15):6953-61. PubMed ID: 11435575
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The decreased expression of Siglec-7 represents an early marker of dysfunctional natural killer-cell subsets associated with high levels of HIV-1 viremia.
    Brunetta E; Fogli M; Varchetta S; Bozzo L; Hudspeth KL; Marcenaro E; Moretta A; Mavilio D
    Blood; 2009 Oct; 114(18):3822-30. PubMed ID: 19710502
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Normalization of natural killer cell function and phenotype with effective anti-HIV therapy and the role of IL-10.
    Parato KG; Kumar A; Badley AD; Sanchez-Dardon JL; Chambers KA; Young CD; Lim WT; Kravcik S; Cameron DW; Angel JB
    AIDS; 2002 Jun; 16(9):1251-6. PubMed ID: 12045490
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased natural killer cell activity in viremic HIV-1 infection.
    Alter G; Malenfant JM; Delabre RM; Burgett NC; Yu XG; Lichterfeld M; Zaunders J; Altfeld M
    J Immunol; 2004 Oct; 173(8):5305-11. PubMed ID: 15470077
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Natural killer cells in spontaneous control of HIV infection.
    Berger CT; Alter G
    Curr Opin HIV AIDS; 2011 May; 6(3):208-13. PubMed ID: 21399495
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lack of correlation between HLA-DR and CD25 "activation" related antigens on CD16+ NK cells in HIV infection.
    Lucia MB; Rutella S; Rumi C; Cauda R
    Eur J Histochem; 1997; 41 Suppl 2():31-2. PubMed ID: 9859770
    [No Abstract]   [Full Text] [Related]  

  • 59. Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients.
    De Maria A; Fogli M; Mazza S; Basso M; Picciotto A; Costa P; Congia S; Mingari MC; Moretta L
    Eur J Immunol; 2007 Feb; 37(2):445-55. PubMed ID: 17273991
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of KIR3DS1 on the cell surface of peripheral blood NK cells facilitates identification of a novel null allele and assessment of KIR3DS1 expression during HIV-1 infection.
    Pascal V; Yamada E; Martin MP; Alter G; Altfeld M; Metcalf JA; Baseler MW; Adelsberger JW; Carrington M; Anderson SK; McVicar DW
    J Immunol; 2007 Aug; 179(3):1625-33. PubMed ID: 17641029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.